Credence Research Logo

Home » Marknad för bioengineerade proteindroger

Marknaden för bioengineerade proteindroger efter typ (monoklonala antikroppar, hormoner, cytokiner och interleukiner, koagulationsfaktorer, enzymer, fusionsproteiner, proteinsubenhetsvacciner, andra); efter sjukdomsindikation (onkologi, diabetes och metabola störningar, autoimmuna sjukdomar, infektionssjukdomar, hjärt-kärlsjukdomar, artrit, medfödda sjukdomar, blodsjukdomar, hudsjukdomar, andningssjukdomar, neurodegenerativa sjukdomar); efter expressionssystem (däggdjurscellkultur, mikrobiella expressionssystem, växtbaserade expressionssystem, insektscelluttryckssystem, andra); efter slutanvändare (läkemedelsföretag, bioteknikföretag, kontraktsforskningsorganisationer, forskningsinstitut) – Tillväxt, andel, möjligheter och konkurrensanalys, 2025 – 2032

Report ID: 206232 | Report Format : Excel, PDF

Begär ett gratisprov

Begär gratis prov

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Begär din provrapport och börja din resa mot välgrundade beslut

Tillhandahåller den strategiska kompassen för branschledare.

cr-clients-logos
Vanliga frågor:
Vad är marknadsstorleken för marknaden för bioengineerade proteindroger år 2025 och prognosen för 2032?

Marknaden för bioingenjörda proteindroger hade en storlek på 391 488,41 miljoner USD år 2025. Marknaden för bioingenjörda proteindroger förväntas nå 588 653,82 miljoner USD år 2032.

Vad är CAGR för marknaden för bioengineerade proteinläkemedel under 2025–2032?

Marknaden för bioengineerade proteindroger förväntas växa med en årlig tillväxttakt (CAGR) på 6% under 2025–2032. Tillväxten stöds av fortsatt innovation inom biologiska läkemedel och en ökande klinisk adoption.

Vilket segment är det största på marknaden för bioengineerade proteindroger?

Monoklonala antikroppar är den största produktsegmentet med en marknadsandel på 40,8% år 2025. Ledarskapet stöds av bred klinisk nytta och stark kommersialiseringsmognad.

Vilka faktorer driver tillväxten av marknaden för bioingenjörda proteindroger?

Tillväxten på marknaden för bioengineerade proteinläkemedel drivs av expanderande biologiska pipeline, ökande börda av kroniska sjukdomar och ökad tillverkningskapacitet. Förbättrad ersättningsskydd stödjer också en bredare adoption.

Vilka är de viktigaste aktörerna på marknaden för bioengineerade proteindroger?

Nyckelföretag inkluderar Abbott, AbbVie, Amgen Inc., Bayer AG, Baxter Healthcare, Biocon, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk och Sanofi.

Vilken region leder marknaden för bioengineerade proteindroger?

Nordamerika leder marknaden för bioengineerade proteindroger med en andel på 43,70 % år 2025. Ledarskapet stöds av stark tillgång till biologiska läkemedel, kapacitet för specialvård och mogna ersättningssystem.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Autologous Conditioned Plasma (ACP) Market

Autologous Conditioned Plasma (ACP) Market size was valued USD 584 million in 2024 and is anticipated to reach USD 1366.31 million by 2032, at a CAGR of 11.2% during the forecast period.

Autogenous Vaccine Market

Autogenous Vaccine Market size was valued USD 465 million in 2024 and is anticipated to reach USD 810.46 million by 2032, at a CAGR of 7.2% during the forecast period.

Combination Therapies In Aesthetics Market

The global combination therapies in aesthetics market was valued at USD 3,690 million in 2024 and is projected to reach USD 6,880.69 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Antioxidants Market

The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.

U.S. Pharma R&D Outsourcing Market

US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.

Reversible Airway Diseases Treatment Market

The Reversible Airway Diseases Treatment Market size was valued at USD 85,518 million in 2024 and is anticipated to reach USD 143671.9 million by 2032, at a CAGR of 6.7 % during the forecast period.

Precision Medicine Market

The Precision Medicine Market size was valued at USD 91,298 million in 2024 and is anticipated to reach USD 204409.6 million by 2032, at a CAGR of 10.6 % during the forecast period.

Postpartum Depression Market

The Postpartum Depression Market size was valued at USD 68 million in 2024 and is anticipated to reach USD 815.92 million by 2032, at a CAGR of 36.5% during the forecast period.

Metastatic Melanoma Cancer Diagnostics Market

The Metastatic Melanoma Cancer Diagnostics Market size was valued at USD 3,622 million in 2024 and is anticipated to reach USD 6364.41 million by 2032, at a CAGR of 7.3 % during the forecast period.

Flavored Empty Capsule Market

The flavored empty capsule market was valued at USD 5,659 million in 2024. The market is projected to reach USD 10,319.51 million by 2032. Growth is expected at a CAGR of 7.8% during the forecast period.

Diabetic Foot Ulcer Treatment Market

The global Diabetic Foot Ulcer Treatment Market size was estimated at USD 5,642.83 million in 2025 and is expected to reach USD 8,796.45 million by 2032, growing at a CAGR of 7.68% from 2025 to 2032.

Dextromethorphan Market

The global Dextromethorphan Market size was estimated at USD 1,284.56 million in 2025 and is expected to reach USD 1,689.23 million by 2032, growing at a CAGR of 4.67% from 2025 to 2032.

Licensalternativ

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$6999

Report delivery within 24 to 48 hours

Snabbkontakt

Europe

+44 7453 598 606

North America

+1 6282 627 656

Email

sales@credenceresearch.com

Begär ett gratisprov

Smallform of Sample request

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialforskare
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Ledningsassistent, Bekaert

Betrodd av

cr-clients-logos

Request Sample